Correlation Between Evogene and Purple Biotech
Can any of the company-specific risk be diversified away by investing in both Evogene and Purple Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Evogene and Purple Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Evogene and Purple Biotech, you can compare the effects of market volatilities on Evogene and Purple Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Evogene with a short position of Purple Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Evogene and Purple Biotech.
Diversification Opportunities for Evogene and Purple Biotech
0.87 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Evogene and Purple is 0.87. Overlapping area represents the amount of risk that can be diversified away by holding Evogene and Purple Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Purple Biotech and Evogene is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Evogene are associated (or correlated) with Purple Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Purple Biotech has no effect on the direction of Evogene i.e., Evogene and Purple Biotech go up and down completely randomly.
Pair Corralation between Evogene and Purple Biotech
Given the investment horizon of 90 days Evogene is expected to generate 0.83 times more return on investment than Purple Biotech. However, Evogene is 1.2 times less risky than Purple Biotech. It trades about -0.08 of its potential returns per unit of risk. Purple Biotech is currently generating about -0.1 per unit of risk. If you would invest 595.00 in Evogene on August 24, 2024 and sell it today you would lose (435.00) from holding Evogene or give up 73.11% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Strong |
Accuracy | 100.0% |
Values | Daily Returns |
Evogene vs. Purple Biotech
Performance |
Timeline |
Evogene |
Purple Biotech |
Evogene and Purple Biotech Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Evogene and Purple Biotech
The main advantage of trading using opposite Evogene and Purple Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Evogene position performs unexpectedly, Purple Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Purple Biotech will offset losses from the drop in Purple Biotech's long position.Evogene vs. Arcus Biosciences | Evogene vs. Fate Therapeutics | Evogene vs. Pluri Inc | Evogene vs. Lexaria Bioscience Corp |
Purple Biotech vs. Pluri Inc | Purple Biotech vs. BioLineRx | Purple Biotech vs. Enlivex Therapeutics | Purple Biotech vs. Anebulo Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Other Complementary Tools
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |